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Abstract
Antiretroviral therapy contributes to decreas-
ing morbidity and mortality, and ultimately to 
increasing survival. In Brazil, there are region-
al differences in HIV epidemiology regarding 
pregnant women and children with HIV/AIDS. 
This study evaluates survival time after AIDS 
diagnosis in 914 children infected by mother-to-
child transmission, reported between 1983 and 
1998 and followed until 2002, in Brazil’s five 
regions. Time between birth and HIV diagnosis 
decreased over the years, mainly in the South 
and Southeast Regions. There was a significant 
improvement in survival; more than 75% of cas-
es were still living four years after diagnosis in 
the 1997-1998 group. This Brazilian study dem-
onstrates that even with regional inequalities 
in health care infrastructure it is possible for a 
developing country to establish an effective sys-
tem of universal and free access to antiretroviral 
therapy that produces a significant increase in 
survival for children with AIDS. 
Vertical Disease Transmission; HIV; Acquired 
Immunodeficiency Syndrome; Survival Analy-
sis; Health Inequalities
Introduction
Since the second half of the 1990s, advances in 
the management of children and adults infected 
with the human immunodeficiency virus (HIV) 
all over the world have brought significant chang-
es in the clinical progression of the infection, 
characterized by lower morbidity of opportunis-
tic conditions and lower mortality from acquired 
immunodeficiency syndrome (AIDS) 1.
Greater understanding about viral and cel-
lular dynamics of HIV infection as well as the 
development of new classes of antiretroviral 
medication have enabled the introduction and 
improvement of treatment, achieving efficacy, 
effectiveness, and efficiency 2,3. In addition, with 
the expansion and better understanding of pro-
phylaxis for opportunistic diseases, with strate-
gies for reducing mother-to-child HIV transmis-
sion, and with broader actions, aimed at giving 
social support to people living with HIV/AIDS, 
the beneficial effects of antiretroviral medication 
have increased 1.
Unfortunately, the technical and scientific 
advances of the past 25 years have not benefited 
or been applied to the majority of the world’s 
HIV infected population 4,5,6. Furthermore, in-
sufficient prevention activities, complicated by 
the complexity of the health and social context, 
have meant that the pandemic has continued to 
grow 7.
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Different political, social, and economic re-
alities in the various regions of the world influ-
ence this epidemic in different ways. One of the 
most obvious examples is access to antiretrovi-
ral therapy; some advances have been made but 
with unequal distribution 8. For example, 90% of 
the people who need antiretroviral therapy, the 
majority of whom live in Sub-Saharan Africa, do 
not receive it 1,9. Different studies have exposed 
this inequality: the death rate by 15 months 
of infants with AIDS in European and North 
American studies is around 5% 10,11. On the 
other hand, in Kinshasa (Democratic Republic 
of Congo), Brazzavile (Republic of Congo), and 
Kigali (Rwanda) the death rate for infants by one 
year was from 12%-39%, depending on the so-
cioeconomic level and stage of the disease in the 
mother. The principal causes of death in these 
children was premature birth, diarrhea, pneu-
monia, AIDS, and meningitis 12,13.
In Brazil, according to 2005 data from 
the Brazilian National STD/AIDS Program 
(PNDST/AIDS), the AIDS epidemic continues 
its growth among the more socioeconomi-
cally vulnerable populations 14. In spite of 
standardized recommended protocols for pre-
vention of mother-to-child transmission and 
antiretroviral therapy in pregnant women 15, 
important differences in their application have 
been observed in the different regions of the 
country 14.
In the case of mother-to-child HIV transmis-
sion, even though the necessary interventions for 
its reduction are available to all pregnant women 
and their children, the difficulties faced by the 
public health care network in making laboratory 
diagnoses of HIV and insufficient prenatal test-
ing coverage, principally in the most vulnerable 
part of the population, and the quality of prenatal 
care, which still leaves much to be desired, result 
in an under-application of these measures. Nev-
ertheless, in spite of all these difficulties, in the 
last few years the incidence of AIDS in children 
has been progressively decreasing in Brazil, al-
beit in an unequal way 14.
Overall mortality from AIDS (recorded by the 
Brazilian Mortality Information System – SIM) has 
remained steady at around 11,000 deaths per year 
since 1998, with an average rate of 6.4 deaths per 
100,000 population, although growth can still be 
observed in the Northern and Southern Regions, 
notably in the State of Rio Grande do Sul, balancing 
a notable reduction in the rates in the State of São 
Paulo and the Federal District. The mortality rate 
among women has also continued growing 14.
With the changes that have been occurring in 
the management of HIV infection, the sustain-
ability of gains in survival needs to be continu-
ally monitored. Important indicators of inequal-
ity in access include the coverage of preventative 
and treatment measures and the monitoring of 
survival time.
Despite their importance, systematic studies 
of the survival of children with AIDS are scarce 
in the literature, mainly carried out in developed 
countries. In Brazil, the PNDST/AIDS has spon-
sored studies of survival in adults and children to 
evaluate the national response to the epidemic.
The general objective of this study is to mea-
sure survival time after AIDS diagnosis in chil-
dren between 0 and 12 years of age in five Brazil-
ian regions diagnosed between 1983 and 1998, 
and followed until 2002.
Method
This is an historical cohort study of AIDS cases in 
children under 13 years of age that were included 
in the Reportable Diseases Database (SINAN), 
with dates of confirmed diagnoses between Janu-
ary 1, 1983 (year of the first recorded pediatric 
AIDS), and December 31, 1998.
The sampling process involved the selection 
of ten Brazilian municipalities: the cities of São 
Paulo, Riberão Preto, Santos, Campinas, and São 
José do Rio Preto (São Paulo State); Rio de Janei-
ro; Porto Alegre (Rio Grande do Sul State); Recife 
(Pernambuco State); Brasília (Federal District); 
and Belém (Pará State). The justification for se-
lecting these municipalities was: inclusion of the 
two largest population centers with the greatest 
reported number of pediatric AIDS cases, Rio de 
Janeiro and São Paulo, both in the Southeastern 
region; inclusion of the city in each of the other 
regions of Brazil with the greatest number of re-
ported AIDS cases in children (North: Belém; 
Northeast: Recife; Central West: Brasília; South: 
Porto Alegre) and four medium-sized cities with 
a large number of AIDS cases reported in chil-
dren (Southeast: Santos, Campinas, São José do 
Rio Preto, and Ribeirão Preto).
At the beginning of the study, these ten cities 
accounted for 59% of the total of 5,138 pediatric 
AIDS cases reported up to December 31, 1998. 
Of the 3,031 cases reported in these cities dur-
ing the study period, 351 were found to be in-
eligible for various reasons. The 2,680 cases that 
remained served as the base for the sample size 
calculation.
Reasons for excluding cases from the sample 
were the following: children who did not fulfill 
the criteria for being AIDS cases in children un-
der 13 that were in force in Brazil at the time of 
the study, or those whose did not fulfill the cri-
teria before December 31, 1998; cases registered 
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in duplicate or with undefined dates. Of the 121 
cases originally reported with the AIDS exposure 
classification “unknown”, 76 (62.8%) were reclas-
sified as being mother-to-child transmission cas-
es after reviewing their files, and were included in 
the study; the other 45 were excluded.
Based on the sample size estimated for a 
statistical power of 90%, a random selection of 
1,268 of the 2,680 eligible children was made for 
the review of medical files and other medical re-
cords. This phase was carried out by contacting 
the health services, locating and surveying the 
records, transcribing the available information 
to a specific instrument for the study, and pre-
paring the data base. Among the 1,268 children 
identified, 1,154 records were located and con-
tained sufficient information for carrying out 
the study, and, among these, a total of 914 were 
classified as vertical AIDS transmission and in-
cluded in this study.
The files and medical records were reviewed 
by qualified health professionals who had re-
ceived training in the requirements for the 
study. This review process took place between 
May 2000 and January 2002. The survival analy-
sis of this sample sought to analyze the occur-
rence of death as an outcome in relation to the 
period of time that began with the diagnosis of 
AIDS. Therefore, the date of AIDS diagnosis for 
each case was re-evaluated, based on the crite-
ria for AIDS at the time of diagnosis. The date 
of death was established through evaluation of 
the medical record and/or local mortality data 
when available. For children whose vital status 
was unknown, the date of censure was defined 
as their last recorded clinic visit.
A data base was constructed and analyzed us-
ing SPSS 12.0 for Windows (SPSS Inc., Chicago, 
U.S.A.). A descriptive analysis of the variables was 
carried out with the objective of characterizing 
the study sample. Survival curves since the date 
of AIDS diagnosis for all types of mortality were 
constructed utilizing the Kaplan-Meier estimator 
16,17,18, which permits estimating survival prob-
ability. Comparison of survival curves by region, 
sex, and year of diagnosis was carried by means of 
a log-rank test or Breslow test 18,19. In all statisti-
cal analyses a significance level of 0.05 was used, 
meaning that associations with a p value less than 
0.05 were considered significant.
This study was approved by the Research 
Ethics Commitee of the Program of STD and 
AIDS of the State of São Paulo and the Escola 
Paulista de Medicina, Universidade Federal de 
São Paulo [Paulista School of Medicine, Federal 
University of São Paulo], following the standards 
established in Resolution nº. 196/96 of the Na-
tional Health Council.
Results
The 914 cases selected (Table 1) were from six 
federal units that represent the five major regions 
of the country and that account for the majority 
of reported cases (69.9%). Over the time period 
studied, there was a significant improvement 
in survival time among Brazilian children with 
AIDS infected through mother-to-child trans-
mission (Figure 1), as has already been presented 
in a previous publication 20. The median survival 
in cases diagnosed before 1988 was 20 months; 
this increased to 24 months in cases diagnosed 
between 1988 and 1992, and to 50 months in 
cases diagnosed between 1993 and 1994. A me-
dian survival time could not be calculated for the 
cases more recently diagnosed, as more than 50% 
were still alive at the end of the study period, and 
more than 75% of the cases were still alive four 
years after diagnosis among cases diagnosed in 
1997 and 1998.
After 60 months, the probability of a being 
alive was 52.1% (95%CI: 48.4-55.7). For males 
(50.1% of cases), it was 51.2% (95%CI: 46.1-56.3), 
and for females (49.9% of cases), it was 52.8% 
(95%CI: 47.7-57.9).
Table 1 shows that the State of São Paulo had 
the majority (87.5%) of the earliest cases diag-
nosed, and also is the state that shows the great-
est reduction in the number of cases in the most 
recent period analyzed. The time from birth to 
diagnosis of HIV infection shows an important 
reduction over time, which indicates better ac-
cess to diagnosis and care, mainly in the South 
and Southeast.
Regarding the cases from the States of Pará 
and Pernambuco and the Federal District, be-
cause they were small samples, representing only 
10% (92) of the cases, the results are mainly of 
descriptive value.
In Figure 2, the survival curves of the Fed-
eral units of Pará, Pernambuco, and the Federal 
District are presented together because they 
represent a small number of cases, and also be-
cause the majority of the cases were diagnosed 
in the most recent period studied. After the date 
of AIDS diagnosis, the median survival time was 
not reached in the cases sampled in Pará, Per-
namuco, and the Federal District. In other words, 
by December, 31, 2001, the probability of survival 
was greater than 50% in these cohorts.
Despite the difficulty of adequate observa-
tion time, Figures 2 and 3 show significant differ-
ences in survival times by location among cases 
sampled in the five states and the Federal Dis-
trict: 93 months in the State of Pará; 122 months 
in the Federal District; 124 months in the State of 
Pernambuco; 133 months in the State of Rio de 
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Janeiro; 134 months in the State of Rio Grande 
do Sul; and 154 months in the State of São Paulo. 
These results should be interpreted with consid-
eration of the different distribution of reporting 
dates (Table 1), which might contribute to dif-
ferences in survival by location.
In Figure 3 there is a significant difference in 
the three curves shown (p = 0.003). Comparing 
only the two curves for Rio de Janeiro and São 
Paulo does not result in a statistically significant 
difference (p = 0.266).
Discussion
Brazil was one of the first countries to adopt 
policies to provide access to quality healthcare 
for carriers of the HIV virus. These strategies are 
manifested in the Law of Industrial Property (Law 
nº. 9,279) and through Law nº. 9,313, which set 
out in 1996, that it is the obligation of the State to 
distribute universally, and free of charge, medica-
tion for the treatment of HIV and AIDS patients. 
The number of medications was gradually in-
creased as they were approved by the Advisory 
Committees for Antiretroviral Therapy 15,21,22.
As a result of this policy, the country has seen 
a significant reduction in mortality and in the 
number of hospitalizations caused by opportu-
nistic diseases 14. On the other hand, geographi-
cally, there is a heterogeneity in the distribution 
and quality of services, with a concentration in 
the South and Southeast and difficulties in the 
North and Northeast. Survival studies can help to 
measure these epidemiological and operational 
differences and quantify differences in health 
care in the country.
Survival time, aside from being an important 
measure for public policy, is fundamental for 
the monitoring and evaluation of intervention 
strategies adopted with the aim of prolonging the 
lives of HIV infected people. Survival is strongly 
influenced by the availability and performance of 
the health service network in different ways.
Access to healthcare and prevention servic-
es, screening programs, the availability of com-
plementary diagnostic methods, and specific 
treatment, clearly impact the natural history of 
the disease, resulting in improved survival that 
can increase or diminish according to the level 
and quality of application of these interven-
tions. With the evolution of technical and scien-
Table 1  
Characteristics of 914 cases of vertical HIV transmission, diagnosed in the period between 1983 and 1998 in Brazil.
                       States
   Pará Pernambuco Federal District São Paulo Rio de Janeiro Rio Grande do Sul
   (n = 19) (n = 39) (n = 34) (n = 533) (n = 130) (n = 159)
   n % n % n % n % n % n %
 Sex             
  Masculine 12 63.2 17 43.6 17 50.0 284 53.3 54 41.5 74 46.5
  Feminine 7 36.8 22 56.4 17 50.0 249 46.7 76 58.5 85 53.5
 Year of diagnosis            
  Before 1988 - - - - - - 14 2.6 - - 2 1.3
  1988-1992 1 5.3 9 23.1 10 29.4 184 34.5 31 23.8 30 18.9
  1993-1994 3 15.8 6 15.4 4 11.8 124 23.3 20 15.4 39 24.5
  1995-1996 4 21.1 10 25.6 7 20.6 134 25.1 29 22.3 37 23.3
  1997-1998 11 57.9 14 35.9 13 38.2 77 14.4 50 38.5 51 32.1
   n Month n Months n Month n Month n  Month n Months
 
 Median time (months) after
 birth for HIV diagnosis             
  1979-1986 - - 3 111.8 - - 34 52.6 10 111.3 8 79.2
  1987-1989 1 100.9 8 35.5 4 42.4 119 23.3 22 43.9 11 33.6
  1990-1991 2 32.7 7 35.7 8 7.9 115 11.4 31 31.4 26 17.8
  1992-1993 8 48.1 3 26.7 9 36.8 104 13.6 19 32.8 32 7.1
  1994-1995 6 25.3 9 13.4 7 18.8 102 7.8 22 24.5 41 9.4
  1996-1998 2 17.6 9 18.3 6 18.5 59 4.7 26 7.2 41 7.0
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Figure 1  
Survival after AIDS diagnosis in 914 cases of vertical transmission, by year of diagnosis, Brazil.
 
tific knowledge, the median time between AIDS 
diagnosis and death has changed dynamically 
over time. This study demonstrates differences 
in this process among federal units analyzed.
Some studies showed a mortality of between 
25% and 50% in the first year of life of HIV-infect-
ed babies and of 85% to 95% during the first five 
years of life before the adoption of antiretrovirals 
23,24. More recent data about the natural history 
of mother-to-child HIV infection indicate that 
the average time of survival has now increased to 
between 6 and 9 years 25.
Chequer et al. 26 recorded a median survival 
time of 5.1 months among 2,135 adult AIDS cas-
es reported between 1982 and 1989. In the State 
of São Paulo, that reported 47% of cases of AIDS 
in the country, Grangeiro et al. 27 observed an 
average survival time between 1985 and 1991 of 
232 days, with a variation by diagnostic category 
from 201 days (mother-to-child transmission) to 
259 days (hemophilia) in 7,480 reported cases. 
Another study, also from the State of São Paulo, 
with 1,066 children infected by vertical transmis-
sion compared the periods from 1988 to 1991 
and from 1992 to 1994, with the period before 
1987. The relative risk of death in the period from 
1988 to 1991 was 0.59 (95%CI: 0.37-0.96) while 
that of the period from 1992 to 1994, when anti-
retroviral therapy had begun to be available, was 
0.45 (95%CI: 0.28-0.72) 28. In the city of New York, 
deaths from AIDS among adults were reduced by 
72% between the years 1994 and 1998 11.
High potency antiretroviral treatment has 
made a substantial contribution to the decline 
of the incidence of opportunistic infections 
among HIV infected patients, with a resulting 
decrease in morbidity and mortality 29. The 
new schemes of antiretrovirals have proven 
their effectiveness in diminishing viral load, in 
increasing CD4 T lymphocyte count, and have 
substantially altered the natural course of HIV 
infection 2,3.
Toxicity associated with the long-term use 
of antiretrovirals has to be considered when be-
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ginning treatment, sometimes precociously, in 
clinically stable children with a relatively pre-
served immune system 30. Aside from this, the 
appearance of antiretroviral-resistant HIV strains 
and problems of adherence to therapy represent 
two of the major causes for treatment failure 31. 
Future studies should help to identify more ef-
fective and reliable therapeutic strategies, with a 
consequent increase in survival.
Starting in the second half of the 1990s, there 
was a significant reduction in mother-to-child 
transmission in the United States 32. This was also 
observed in Brazil starting in 1998 14, as well as 
an increase in survival to the period of adoles-
cence and adulthood in the population of HIV 
infected children. The majority of these children 
and adolescents receive long-term antiretroviral 
therapy 33.
Among children infected by mother-to-
child transmission, mortality was reduced 67% 
between 1997 and 2002, parallel to the growth 
in the use of triple or quadruple antiretroviral 
medication. Progression to AIDS and rates of 
hospitalization have also fallen substantially. 
But in spite of an 80% decrease in the rates of 
hospitalizations, the absolute number of hos-
pitalizations only decreased 25%; the growing 
numbers of children infected with HIV who 
need care because of complications, principally 
in the North, Northeast, and South of the coun-
try, require better evaluation, prophylaxis, and 
treatment 14,22.
Survival of HIV infected children has been 
analyzed in various cohorts around the world 
10,34,35, demonstrating the impact antiretrovirals 
have on time and quality of survival, and re-em-
phasizing the importance of access of all socio-
economic strata to these medications 6,36.
Brazil has also experienced a significant in-
crease in survival of children with AIDS 20. In this 
Figure 2  
Survival after AIDS diagnosis in cases of vertical transmission in the Brazilian States of Pará, Pernambuco and the Federal 
District, during the period from 1983 to 1998, and followed until 2002.
Breslow test for comparison of the three curves: p = 0.510.
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study, over the lengthy period analyzed, there 
was a significant improvement in the survival 
time among Brazilian children with AIDS that 
had been infected by mother-to-child transmis-
sion; more than 75% of the cases were still living 
four years after diagnosis among those cases di-
agnosed in 1997 and 1998.
The national results 20,28 of survival since the 
date of diagnosis of AIDS in cases of mother-to-
child transmission are similar to those reported in 
the United States, where among cases diagnosed 
in 1998, the survival to 36 months was 87% 37.
Other studies demonstrate a similar increase 
in survival, even though the degree of improve-
ment and the actual levels of survival attained 
are difficult to compare. The majority of accounts 
of survival time among cases of AIDS through 
mother-to-child transmission are based on co-
horts of HIV infected children who were diag-
nosed at birth or immediately afterwards. Surviv-
al time is normally calculated from date of birth 
or date of HIV infection diagnosis instead of the 
date of meeting the criteria for AIDS case defini-
tion, thus affecting the reported time of survival. 
For example, survival until the age of five years in 
Canadian children infected via mother-to-child 
transmission increased from 72% among those 
born during the period between 1992 and 1995 to 
92% among those born in 1996 38. In the United 
States, survival until five years increased from 
72% to 83% when comparing children born be-
fore and after 1994 39.
The present study was based on national AIDS 
reporting data, and this method has the advan-
tage of being representative of the population of 
this age group and transmission method. Regard-
ing cases that were not reported until the criteria 
for AIDS were met, it is only possible to make un-
biased estimates about survival starting from this 
point. Adding together the median age of AIDS 
diagnosis plus the median survival after the diag-
nosis gives an estimate of median survival after 
Figure 3  
Survival after AIDS diagnosis in cases of vertical transmission from the Brazilian States of Rio de Janeiro, Rio Grande do Sul, 
and São Paulo, during the period from 1983 to 1998, and followed until 2002.
Breslow test for comparison of the three curves: p = 0.003.
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birth. But this would be an underestimate insofar 
as healthier infected children that were not diag-
nosed or still had not fulfilled the AIDS case crite-
ria are not included in the denominator.
This situation could change in the future in 
Brazil, because since 2000 strategies for the re-
duction of mother-to-child transmission have 
made the inclusion of all pregnant women and 
children exposed to HIV in the SINAN registry 
a norm.
Despite the fact that the ten cities selected 
are representative from a geographical point 
of view and are responsible for the majority of 
Brazilian reported AIDS cases in children, it is 
possible that under-reporting may be higher 
and that absolute survival, as well as recent im-
provements in survival, may be lower in other 
areas of Brazil. It is estimated that under-report-
ing of AIDS is relatively low in Brazil 40, but the 
cases not reported could have a lower survival 
time, as may have occurred in 16% of the origi-
nal sample of this study, for which there was no 
information available. Even though these fac-
tors could generate an overestimate of survival, 
they could not have caused the increase that 
has been observed in survival, unless the mag-
nitude of the bias has increased substantially 
over time.
One factor that could have influenced surviv-
al time is early diagnosis. The definition for AIDS 
cases in Brazil was reviewed in 1994 and made 
more sensitive, even though the T cell CD4+ lym-
phocyte count only became widely available in 
1997 41. On the other hand, the improvement of 
initial treatment helps retard the progression of 
the disease, consequently contributing to an in-
crease in survival and to a delay in meeting the 
case criteria for AIDS.
Frequently the reporting of an AIDS case oc-
curs very close to, or even after, death. This cre-
ates an important problem for survival analyses, 
in that the inclusion of these patients produces a 
bias by systematically reducing the survival pe-
riod observed. Nevertheless, we have followed 
the procedures used in many other studies by 
including these cases, even though this results in 
shorter observed survival times 42.
The most important methodological prob-
lem in survival studies is the validity of the un-
derlying data. This includes questions such as: 
AIDS case definition and its evolution over time; 
coverage (sensitivity) and quality (specificity) of 
the case registries; quality of clinical manage-
ment; definition of date of AIDS diagnosis, and 
access to health services. Of principal influence 
are the last factors cited, as can be seen in the re-
sults of this study, considering that the Southeast 
and South regions present, as much as possible, 
better healthcare for the carriers of this disease. 
But it is still necessary to carry out further stud-
ies to better understand regional inequities.
Conclusions
Even though there has been a reduction in moth-
er-to-child transmission and the Brazilian Uni-
fied National Health System (SUS) offers free pre-
natal care, HIV testing, and treatment for AIDS, 
as well as interventions with Zidovudine (AZT) 
at the time of delivery for the infected expectant 
mothers and exposed babies, it can be observed 
that opportunities for prenatal detection of HIV 
infection are still being missed. This makes the 
control of AIDS acquired by mother-to-child 
transmission more difficult, as shown in a recent 
study of mother-to-child HIV transmission rates 
in the different regions of Brazil 43.
In spite of limitations, this study covered dif-
ferent phases of the epidemic, different case defi-
nitions, and different therapy schemes for treat-
ment and prophylaxis of opportunistic infec-
tions. The results suggests that the mortality rate 
was falling both during and after the period that 
corresponds to the introduction of antiretroviral 
therapy and development of clinical monitoring 
in Brazil. On the other hand, the inequalities ob-
served in survival time reflect the real epidemio-
logical and operational context of the country.
The advent of new therapeutic options for 
HIV, along with better knowledge of viral behav-
ior and of the body’s response to infection, point 
to the need for continuous improvements in 
therapeutic schemes and duration.
Because of the increase in survival of chil-
dren, coordination and exchange of information 
with healthcare services which treat adults with 
HIV/AIDS are increasingly important, to meet 
the medical, social, and psychological needs of 
children who are beginning their adolescent and 
adult phases of life. In any case, as children and 
adolescents receiving antiretroviral therapy pro-
ceed to the hormonal changes and growth asso-
ciated with puberty, the long term complications 
and toxicities from chronic exposure to antiret-
roviral therapies will require careful monitoring 
and evaluation.
Analysis of the Brazilian experience is impor-
tant, as it demonstrates that it is possible for a 
developing country with great geographical ex-
tension to establish an effective system for the 
universal and free access to antiretroviral thera-
py. It also demonstrates that such care, even in a 
country that presents regional difficulties for the 
organization of an ideal healthcare infrastructure, 
can make a significant difference in survival.
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Resumo
A terapia anti-retroviral contribui para a diminuição 
da morbidade e da mortalidade, com conseqüente au-
mento da sobrevida. No Brasil, há diferenças regionais 
relativas à dinâmica da epidemia do HIV e ao seu en-
frentamento no grupo das gestantes e das crianças com 
HIV/AIDS. Este estudo verifica o tempo de sobrevida 
após o diagnóstico de AIDS em 914 crianças infectadas 
por transmissão vertical, entre os anos de 1983 e 1998, 
e acompanhadas até 2002, nas cinco regiões brasilei-
ras. O tempo do nascimento ao diagnóstico de infecção 
pelo HIV, ao longo dos anos, apresenta uma diminui-
ção, principalmente nos estados das regiões Sul e Su-
deste. Houve melhora significativa da sobrevivência, 
mais de 75% dos casos ainda estavam vivendo quatro 
anos após o diagnóstico, no grupo de 1997 e 1998. Es-
ta análise brasileira mostra ser possível para um país 
em desenvolvimento estabelecer um sistema efetivo de 
acesso gratuito e universal à terapia anti-retroviral, 
mesmo com dificuldades regionais para a organização 
de uma infra-estrutura ideal de saúde, tendo como re-
sultado um aumento significativo da sobrevivência.
Transmissão Vertical de Doença; HIV; Síndrome de 
Imunodeficiência Adquirida; Análise de Sobrevida; 
Desigualdades em Saúde 
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